NO20055883L - Fremgangsmate for fremstilling av racemisk 2-{[2-(4-hydroksfenyl)etyl]tio}-3-[4-(2-{4-[(metylsulfonyl)oksy]fenoksy}etyl)fenyl]-propansyre - Google Patents
Fremgangsmate for fremstilling av racemisk 2-{[2-(4-hydroksfenyl)etyl]tio}-3-[4-(2-{4-[(metylsulfonyl)oksy]fenoksy}etyl)fenyl]-propansyreInfo
- Publication number
- NO20055883L NO20055883L NO20055883A NO20055883A NO20055883L NO 20055883 L NO20055883 L NO 20055883L NO 20055883 A NO20055883 A NO 20055883A NO 20055883 A NO20055883 A NO 20055883A NO 20055883 L NO20055883 L NO 20055883L
- Authority
- NO
- Norway
- Prior art keywords
- ethyl
- methylsulfonyl
- thio
- hydroxyphenyl
- phenoxy
- Prior art date
Links
- PGZGQQFVPOZCAQ-UHFFFAOYSA-N 2-[2-(4-hydroxyphenyl)ethylsulfanyl]-3-[4-[2-(4-methylsulfonyloxyphenoxy)ethyl]phenyl]propanoic acid Chemical compound C1=CC(OS(=O)(=O)C)=CC=C1OCCC(C=C1)=CC=C1CC(C(O)=O)SCCC1=CC=C(O)C=C1 PGZGQQFVPOZCAQ-UHFFFAOYSA-N 0.000 title abstract 3
- 239000012442 inert solvent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1896—Compounds having one or more Si-O-acyl linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
- C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0314260.1A GB0314260D0 (en) | 2003-06-19 | 2003-06-19 | Therapeutic agents |
| PCT/GB2004/002599 WO2004113285A1 (fr) | 2003-06-19 | 2004-06-16 | Procede d'elaboration d'acide racemique 2-{[2-(4-hydroxyphenyl)ethyl]thio}-3-[4-(2-{4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]-propanoique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20055883L true NO20055883L (no) | 2006-01-09 |
Family
ID=27636892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20055883A NO20055883L (no) | 2003-06-19 | 2005-12-12 | Fremgangsmate for fremstilling av racemisk 2-{[2-(4-hydroksfenyl)etyl]tio}-3-[4-(2-{4-[(metylsulfonyl)oksy]fenoksy}etyl)fenyl]-propansyre |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7429675B2 (fr) |
| EP (1) | EP1638929A1 (fr) |
| JP (1) | JP2006527751A (fr) |
| KR (1) | KR20060010840A (fr) |
| CN (1) | CN1835918A (fr) |
| AU (1) | AU2004249487A1 (fr) |
| BR (1) | BRPI0411450A (fr) |
| CA (1) | CA2529252A1 (fr) |
| GB (1) | GB0314260D0 (fr) |
| IL (1) | IL172376A0 (fr) |
| MX (1) | MXPA05013716A (fr) |
| NO (1) | NO20055883L (fr) |
| WO (1) | WO2004113285A1 (fr) |
| ZA (1) | ZA200509944B (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0104333D0 (sv) | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
| BR0311932A (pt) | 2002-06-20 | 2005-03-22 | Astrazeneca Ab | Composto, formulação farmacêutica, método para tratar ou prevenir resistência à insulina, uso de um composto, processo para preparar um composto, e, tratamento combinado |
| GB0314075D0 (en) * | 2003-06-18 | 2003-07-23 | Astrazeneca Ab | Therapeutic agents |
| GB0427524D0 (en) | 2004-12-16 | 2005-01-19 | Astrazeneca Ab | Chemical process |
| RU2480453C2 (ru) * | 2007-03-08 | 2013-04-27 | Альбирео Аб | Новые соединения |
| FR2986804A1 (fr) * | 2012-02-09 | 2013-08-16 | Servier Lab | Procede de synthese enzymatique de l'acide (7s) 3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene 7-carboxylique ou de ses esters, et application a la synthese de l'ivabradine et de ses sels |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3683512D1 (de) | 1985-02-25 | 1992-03-05 | Mitsubishi Gas Chemical Co | Verfahren zur optischen isomerisierung von optisch aktiver aminosaeure und verfahren zur herstellung von optisch aktiver aminosaeure. |
| JPS61197530A (ja) | 1985-02-25 | 1986-09-01 | Mitsubishi Gas Chem Co Inc | ラセミ化法 |
| TW472047B (en) | 1994-02-04 | 2002-01-11 | Merck & Co Inc | Process for making HIV protease inhibitors |
| SE9801992D0 (sv) * | 1998-06-04 | 1998-06-04 | Astra Ab | New 3-aryl-2-hydroxypropionic acid derivative I |
| MA26634A1 (fr) | 1998-06-04 | 2004-12-20 | Astra Ab | Nouveaux derives de l'acide 3-aryl propionique et analogues |
| SE0104333D0 (sv) | 2001-12-19 | 2001-12-19 | Astrazeneca Ab | Therapeutic agents |
-
2003
- 2003-06-19 GB GBGB0314260.1A patent/GB0314260D0/en not_active Ceased
-
2004
- 2004-06-16 EP EP04736920A patent/EP1638929A1/fr not_active Withdrawn
- 2004-06-16 KR KR1020057024130A patent/KR20060010840A/ko not_active Withdrawn
- 2004-06-16 WO PCT/GB2004/002599 patent/WO2004113285A1/fr not_active Ceased
- 2004-06-16 AU AU2004249487A patent/AU2004249487A1/en not_active Abandoned
- 2004-06-16 CA CA002529252A patent/CA2529252A1/fr not_active Abandoned
- 2004-06-16 CN CNA2004800231458A patent/CN1835918A/zh active Pending
- 2004-06-16 BR BRPI0411450-7A patent/BRPI0411450A/pt not_active IP Right Cessation
- 2004-06-16 JP JP2006516435A patent/JP2006527751A/ja not_active Withdrawn
- 2004-06-16 MX MXPA05013716A patent/MXPA05013716A/es unknown
- 2004-06-16 US US10/561,161 patent/US7429675B2/en not_active Expired - Fee Related
-
2005
- 2005-12-05 IL IL172376A patent/IL172376A0/en unknown
- 2005-12-07 ZA ZA200509944A patent/ZA200509944B/en unknown
- 2005-12-12 NO NO20055883A patent/NO20055883L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US7429675B2 (en) | 2008-09-30 |
| BRPI0411450A (pt) | 2006-07-18 |
| WO2004113285A1 (fr) | 2004-12-29 |
| JP2006527751A (ja) | 2006-12-07 |
| MXPA05013716A (es) | 2006-03-08 |
| AU2004249487A1 (en) | 2004-12-29 |
| IL172376A0 (en) | 2009-02-11 |
| GB0314260D0 (en) | 2003-07-23 |
| US20060167309A1 (en) | 2006-07-27 |
| KR20060010840A (ko) | 2006-02-02 |
| ZA200509944B (en) | 2006-12-27 |
| CN1835918A (zh) | 2006-09-20 |
| CA2529252A1 (fr) | 2004-12-29 |
| EP1638929A1 (fr) | 2006-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007096889A3 (fr) | Procede de preparation de montelukast et de ses sels | |
| PL1937065T3 (pl) | Nowe sole lizynowe pochodnych kwasu 4-((fenoksyalkilo)tio)fenoksyoctowewgo | |
| EP2578574A4 (fr) | Dérivé de dibenzylamine optiquement actif et procédé pour sa préparation | |
| CY2012031I1 (el) | Χορηγουμενη απο του στοματος φαρμακοτεχνικη μορφη για τον 3-[(2-{[4-(εξυλοξυκαρβονυλαμινο-ιμινο-μεθυλο)-φαινυλαμινο]-μεθυλ}-1-μεθυλ-1η-βενζιμιδαζολο-5-καρβονυλο)-πυριδιν-2-υλ-αμινο]-προπιονικο αιθυλεστερα ή τα αλατα αυτου | |
| NO20074642L (no) | Fremgangsmate for a lage trans-1-((1R,3S)-6-klor-3-fenylindan-1-yl)-3,3-dimetylpiperazin | |
| NO20055883L (no) | Fremgangsmate for fremstilling av racemisk 2-{[2-(4-hydroksfenyl)etyl]tio}-3-[4-(2-{4-[(metylsulfonyl)oksy]fenoksy}etyl)fenyl]-propansyre | |
| ATE394094T1 (de) | Tablette enthaltend 3-((2-ä(4- (hexyloxycarbonylamino-imino-methyl)-phenylamin )-methylü-1-methyl-1h-benzimidazol-5-carbonyl)- pyridin-2-yl-amino)-propionsäure-ethylester oder dessen salze | |
| ATE347550T1 (de) | Polymorph von 4-(2-(4-(1-(2-ethoxyethyl)-1h- benzimidazol-2-yl)-1-piperidinyl)ethyl)-alpha, alpha-dimethylbenzolessigsäure | |
| DE602007011231D1 (de) | Triazolonderivat | |
| EE200200278A (et) | (S)-2-etoksü-3-[4-(2-{4-metaansulfonüüloksüfenüül}etoksü)fenüül]propaanhappe kristalne vorm | |
| AR053890A1 (es) | Proceso para la sintesis de derivados de piridinil-pirimidinilo | |
| PE20030978A1 (es) | Metabolitos del acido(3-{[4-terc-butilbencil)-(piridin-3-sulfonil)-amino]-metil}-fenoxi)-acetico | |
| UA92354C2 (en) | Amino acid salts of rosiglitazone | |
| AU2002365626A1 (en) | Process for the preparation of (2s)-3-(4-({(4-(aminocarbonyl)-1-piperidinyl)carbonyl}oxy) phenyl)2-{((2s)-4-methyl-2-{(2-(2-methylphenoxy)acetyl)amino}pentanoyl)amino(propanoic acid and intermediates therefore | |
| IL172633A0 (en) | Amine salts of (-)-2-{[2-(4-hydroxyphenyl) ethyl]thio}-3-[4-(2-{4-[(methylsulfonyl)oxy]phenoxy} | |
| PL2062881T3 (pl) | Sposób wytwarzania N-(difenylometylo)piperazyn | |
| PL382346A1 (pl) | Sposób wytwarzania soli sodowej kwasu 1-(((1(R)-(3-(2-(7--chloro-2- chinolinylo)-etenylo)fenylo)-3-(2-(1-hydroksy-1- metyloetylo)fenylo)propylo)sulfanylo)metylo)-cyklopropanooctowego | |
| HK1087395A (en) | Process for the preparation of racemic 2-{[2-(4-hydroxyphenyl)ethyl]thio} -3-{4-(2-{4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]-propanoic acid | |
| AU2003235814A8 (en) | Novel process for the preparation of trans-3- ethyl-2,5- dihydro-4- methyl-n-(2-( 4-(((((4-methyl cyclohexyl) amino)carbonyl) amino)sulfonyl) phenyl)ethyl) -2-oxo-1h-pyrrole -1-carboxamide | |
| EA200701740A1 (ru) | Кристаллическое основание транс-1-((1r,3s)-3-фенил-6-хлороиндан-1-ил)-3,3-диметилпиперазина | |
| ATE486864T1 (de) | Enantioselektive herstellung von benzimidazolderivaten und ihren salzen | |
| JP2006527751A5 (fr) | ||
| TW200640843A (en) | Therapeutic agents | |
| MXPA05013826A (es) | Sal de potasio o de sodio de acido (-)-2-{o2 -(4-hidroxifenil) etil]-tio-3 -o4-(2-{4- o(metilsulfonil) oxi]fenoxi} etil)fenil] propanoico y su uso en la medicina. | |
| NO20033880L (no) | Fremgangsmåte for fremstilling av optiske aktive propoksyanilinderivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |